Video

Dr. Rubenstein on the conversion factor for 2023

Author(s):

Urology Times staff

“Every year, we see our reimbursements go down. Every year, there seem to be some sort of patch,” says Jonathan Rubenstein, MD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this interview, Jonathan Rubenstein, MD, discusses the conversion factor for 2023. Rubenstein is compliance officer and medical director of coding and reimbursement, United Urology Group and Chesapeake Urology, Towson, Maryland.

      Related Videos
      Joy Maulik, CRNP, on the importance of genetic testing in prostate cancer
      Joy Maulik, CRNP, on the importance of genetic testing in prostate cancer
      Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
      Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
      3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
      How rBCG EAP could open up access for Anktiva in bladder cancer
      Raymond Xu, MD, answers a question during a Zoom video interview
      Raymond Xu, MD, discusses Cost Plus Drugs and urogynecologic medications
      Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
      Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
      Jason Hafron, MD, considers the future for AI in urology
      Jason Hafron, MD, considers the future for AI in urology
      Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
      How recombinant BCG could ease strain of supply issues
      Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
      Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
      Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
      Suzanne B. Merrill, MD, FACS, on EAP program for recombinant BCG
      Mark Edney, MD, highlights pending telehealth legislation
      Mark Edney, MD, highlights pending telehealth legislation
      Related Content
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      April 14th 2025

      Coding Q&A: How to bill for second-generation stone device

      Jonathan Rubenstein, MD Mark Painter
      Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.
      Health policy in urology: 2024 AUA Advocacy Summit recap
      March 21st 2024

      Health policy in urology: 2024 AUA Advocacy Summit recap

      Urology Times staff
      In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
      Closeup financial chart with uptrend line candlestick graph in stock market on blue color monitor background | Image Credit: © iamchamp - stock.adobe.com
      March 21st 2025

      Money Matters: How to cope with market volatility in 2025

      Jeff Witz, CFP
      "If you determine you can invest in a volatile environment, the best approach is to do so over a period of time," writes Jeff Witz, CFP.
      How APPs can bridge the gap in urologist shortages
      August 28th 2023

      How APPs can bridge the gap in urologist shortages

      Urology Times staff
      In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
      Two doctors being discussing patient history | Image Credit: © Freedomz - stock.adobe.com
      February 19th 2025

      Level of service for vasectomy prompts coding confusion

      Jonathan Rubenstein, MD Mark Painter
      "With the requirements for an E/M code as noted above, we agree with you that the supporting documentation, if appropriately documented, would support a level 3 outpatient visit for a visit regarding counseling for contraception or family planning," write Jonathan Rubenstein, MD, and Mark Painter.
      Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025
      February 10th 2025

      Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

      Arpeet Shah, MD
      Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.
      © 2025 MJH Life Sciences

      All rights reserved.